Company Search:
Advanced Search
Sponsored Links
Marinomed Biotech AG Company Snapshot
Marinomed Biotech AG operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Marinomed Biotech AG with three other pharmaceutical manufacturers in Europe: Camurus AB of SWEDEN (2018 sales of 49.32 million Swedish Kronor [US$4.85 million] of which 54% was License and milestone revenues), Enzymatica AB (publ) of SWEDEN (52.56 million Swedish Kronor [US$5.17 million] of which 100% was Medical Devices), and Nicox SA which is based in FRANCE (4.03 million Euros [US$4.34 million] ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Marinomed Biotech AG
  Stock Performance Chart for Marinomed Biotech AG
  Stock Data: Recent Stock Performance:
  Current Price (4/3/2020): 92.00
(Figures in Euros )
1 Week 1.1%   13 Weeks -5.2%  
4 Weeks -9.8%   52 Weeks 16.5%  
Marinomed Biotech AG Key Data:
  Ticker: MARI Country: Austria
  Exchanges: VIE Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 4,666,276
(Year Ending Jan 2019).
Employees: 32
  Currency: Euros Market Cap: 135,219,024
  Fiscal Yr Ends: December Shares Outstanding: 1,469,772
  Share Type: STAMMAKTIE Closely Held Shares: 935,871
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.